New York, NY USA

Our News on Newswise

Memorial Sloan Kettering Opens First Pediatric CAR T Cell Clinical Trial

Researchers from Memorial Sloan Kettering Cancer Center (MSK) are pioneering a new groundbreaking clinical trial for children and young adults with relapsed or treatment-resistant acute lymphocytic leukemia (ALL) by using one of the most promising...
10-Apr-2015 9:05 AM EDT

Memorial Sloan Kettering Debuts New Mobile Application for Patients

Memorial Sloan Kettering Cancer Center (MSK) has debuted MyMSK, a new mobile application. The app, compatible with iPad, iPhone, and all iOS devices, allows MSK patients to quickly and easily access their lab and radiology results, view their...
23-Feb-2015 4:00 PM EST

NIH Awards Seven-Year Grant to Weill Cornell Medical College to Tackle Global Tuberculosis Epidemic

In an effort to stop tuberculosis (TB) from becoming progressively less treatable worldwide, the National Institutes of Health has awarded Weill Cornell Medical College more than $6.2 million in first-year funding to support a research collaboration...
19-Feb-2015 11:00 AM EST

Memorial Sloan Kettering Study Shows New Kind of Targeted Drug Has Promise for Leukemia Patients

A new type of cancer therapy that targets an oncometabolite produced dramatic results in patients with advanced leukemia in an early-phase clinical trial.
7-Dec-2014 12:30 PM EST

Studies Led by Memorial Sloan Kettering Investigators Show Immunotherapy Drugs Improve Outcomes in Hodgkin Lymphoma Patients

In recent years, a number of scientific breakthroughs have led to the development of drugs that unleash the power of the immune system to recognize and attack cancer. For Classical Hodgkin lymphoma patients, two phase I studies are already...
6-Dec-2014 1:00 PM EST

Positive Data from Pivotal Phase III Study Could Improve Standard of Care for Hodgkin Lymphoma Patients

In a late-stage clinical trial, Hodgkin lymphoma patients who received brentuximab vedotin post-transplant lived longer without disease progression than patients who received only supportive care.
6-Dec-2014 11:00 AM EST

Memorial Sloan Kettering Team Makes Key Discovery in Understanding Immunotherapy’s Successes—and Its Failures

A collaborative team of leaders in the field of cancer immunology from Memorial Sloan Kettering Cancer Center has made a key discovery that advances the understanding of why some patients respond to ipilimumab, an immunotherapy drug, while others do...
19-Nov-2014 5:00 PM EST

Memorial Sloan Kettering Brings Cancer Care Closer to Home for Hudson Valley Residents

Memorial Sloan Kettering’s suburban presence is expanding with its newest and largest state-of-the-art facility set to welcome patients on October 6 in West Harrison, New York.
1-Oct-2014 9:50 AM EDT

Our YouTube Videos